BETZ STEPHEN F. (Chief Scientific Officer) received a stock award from CRINETICS PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/25/2026ACC: 0001628280-26-011718
Officer· Chief Scientific Officer
Since Oct 2021
+77K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
77K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+30K
Price / share
—
Trade value
—
% of position
25.5%
2/23/2026
117.71K→147.71K
Total
Net shares
+30K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/23/2026 | A · Award | +30K | — | — | 25.5% | 117.71K | 147.71K |
| Total | +30K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
47K shares
Shares
+47K
Strike price
43.79
Held after
47K
Exercisable
—
2/23/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock47K shares | 2/23/2026 | A · Award | +47K | 43.79 | — | 47K |